Metropolitan Life Insurance Company (MetLife)’s Astria Therapeutics ATXS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,641	Closed	-$37.2K	–	206
2024 Q1	$37.2K	Buy	2,641 +655	+33%	+$9.22K	﹤0.01%	1554
2023 Q4	$15.3K	Buy	1,986 +580	+41%	+$4.45K	﹤0.01%	2030
2023 Q3	$10.5K	Hold	1,406	–	–	﹤0.01%	2183
2023 Q2	$11.7K	Buy	+1,406	New	+$11.7K	﹤0.01%	2223